Skip to content

Disc Medicine IRON Deferred Tax Assets and Other Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
Beam Therapeutics logo
Beam TherapeuticsBEAM
Travere Therapeutics, Inc. logo
Travere Therapeutics, Inc.TVTX
BridgeBio Pharma logo
BridgeBio PharmaBBIO

Other financials

Income statement

See full
Operating income-$69.5M-74.0%
Net income-$63.5M-86.3%
EPS (diluted)-$1.65-61.8%

Balance sheet

See full
Cash & equivalents$88.9M-27.5%
Total debt$31.1M+1.4%
Total equity$688.4M+4.3%
Total assets$750.2M+5.8%

Cash flow

See full
Operating cash flow-$62.2M-50.4%
CapEx--100%
Free cash flow-$62.2M-47.4%

Valuation

See full
Market cap$2.69B+42.2%
Enterprise value$2.63B+46.7%

Returns & leverage

See full
Return on equity-35.8%+41.3pp
Debt / equity0.0×
Current ratio24×-13.6×

Where this comes from

Reported directly by Disc Medicine in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Disc Medicine’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Disc Medicine's deferred tax assets and other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Disc Medicine's deferred tax assets and other non-current assets?
Disc Medicine (IRON) reported deferred tax assets and other non-current assets of $721K in Q1 2026.
How has Disc Medicine's deferred tax assets and other non-current assets changed year-over-year?
Disc Medicine's deferred tax assets and other non-current assets decreased by 14.1% year-over-year, from $839K to $721K.
What is the long-term trend for Disc Medicine's deferred tax assets and other non-current assets?
Over 4 years (2021 to 2025), Disc Medicine's deferred tax assets and other non-current assets has grown at a 41.7% compound annual growth rate (CAGR), from $180K to $726K.